Henry Schein, Inc.
Third Quarter 2019 Analyst Presentation Growth Since Going Public
From Continuing Operations
(in millions, except per share data)
Reconciling Items | ||||||||||||||||||||||||||||||||
Tax Reorganizatrion | ||||||||||||||||||||||||||||||||
Charges related to HS | ||||||||||||||||||||||||||||||||
Special Management | One, Entity Outside | Transition Tax on | ||||||||||||||||||||||||||||||
U.S., and Animal Health | ||||||||||||||||||||||||||||||||
GAAP Basis | Compensation Costs | Litigation Settlement | Restructuring Costs | Spin-Off | Repatriated Earnings | Non-GAAP | ||||||||||||||||||||||||||
Net Sales | 1995 | 2018 | CAGR | 1995 | 2018 | 1995 | 2018 | 1995 | 2018 | 1995 | 2018 | 1995 | 2018 | 1995 | 2018 | CAGR | ||||||||||||||||
$ | 583.6 | $ | 9,417.6 | 13% | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | $ | 583.6 | $ | 9,417.6 | 13% | |||||||||||
Operating Income | $ | (2.5) | $ | 600.6 | -227% | $ | 20.8 | $ | - | $ | 38.5 | $ | 54.4 | $ | 18.3 | $ | 693.5 | 17% | ||||||||||||||
Operating Margin | -0.43% | 6.38% | 681 | bp | 3.13% | 7.36% | 423 bp | |||||||||||||||||||||||||
Net Income | $ | (11.0) | $ | 430.7 | -217% | $ | 19.6 | $ | - | $ | 28.9 | $ | 40.8 | $ | (3.6) | $ | (10.0) | $ | 8.6 | $ | 486.8 | 19% | ||||||||||
Diluted EPS | $ | (0.21) | $ | 2.80 | -212% | $ | 0.37 | $ | - | $ | 0.19 | $ | 0.27 | $ | (0.02) | $ | (0.07) | $ | 0.16 | $ | 3.17 | 14% |
Henry Schein, Inc.
Third Quarter 2019 Analyst Presentation Full Year 2018 Financial Highlights From Continuing Operations
(in millions, except per share data)
Reconciling Items | |||||||||||||||||||||||||||||||||||||||||
Tax Reorganizatrion | |||||||||||||||||||||||||||||||||||||||||
Charges related to HS | |||||||||||||||||||||||||||||||||||||||||
Loss on Sale of | One, Entity Outside | ||||||||||||||||||||||||||||||||||||||||
Equity | U.S., and Animal | Deferred Tax | Transition Tax on | ||||||||||||||||||||||||||||||||||||||
GAAP Basis | Litigation Settlement | Restructuring | Investment | Health Spin-Off | Adjustment | Repatriated Earnings | Total Reconciling Items | Non-GAAP | |||||||||||||||||||||||||||||||||
Net Sales | 2017 | 2018 | Growth | 2017 | 2018 | 2017 | 2018 | 2017 | 2018 | 2017 | 2018 | 2017 | 2018 | 2017 | 2018 | 2017 | 2018 | 2017 | 2018 | Growth | |||||||||||||||||||||
$ | 8,883.4 | $ | 9,417.6 | 6.0% | $ | - | $ | - | $ | 8,883.4 | $ | 9,417.6 | 6.0% | ||||||||||||||||||||||||||||
Operating Income | $ | 669.8 | $ | 600.6 | -10.3% | $ | 5.3 | $ | 38.5 | $ | 54.4 | $ | 5.3 | $ | 92.9 | $ | 675.1 | $ | 693.5 | 2.7% | |||||||||||||||||||||
Operating Margin | 7.54% | 6.38% | (116) | bp | 7.60% | 7.36% | (24) | bp | |||||||||||||||||||||||||||||||||
Net Income | $ | 293.2 | $ | 430.7 | 46.9% | $ | 3.2 | $ | 28.9 | $ | 40.8 | $ | 17.6 | $ | (3.6) | $ | 3.0 | $ | 140.0 | $ | (10.0) | $ | 163.8 | $ | 56.0 | $ | 457.0 | $ | 486.8 | 6.5% | |||||||||||
Diluted EPS | $ | 1.85 | $ | 2.80 | 51.4% | $ | 0.02 | $ | 0.19 | $ | 0.27 | $ | 0.11 | $ | (0.02) | $ | 0.02 | $ | 0.88 | $ | (0.07) | $ | 1.03 | $ | 0.37 | $ | 2.89 | $ | 3.17 | 9.7% |
Henry Schein, Inc.
Third Quarter 2019 Analyst Presentation Q3 2019 - Financial Highlights
From Continuing Operations
(in millions, except per share data)
Reconciling Items | ||||||||||||||||
2019-Restructuring, and Tax Credit related to | ||||||||||||||||
the Animal Health Spin-Off | ||||||||||||||||
2018-Restructuring, Litigation Settlements, | ||||||||||||||||
One Time Tax on Reorganization Related to | ||||||||||||||||
HS One, and Transitional Tax on Repatriated | ||||||||||||||||
GAAP Basis | Foreign Earnings | Non-GAAP | ||||||||||||||
Net Sales | Q3 2018 | Q3 2019 | Growth | Q3 2018 | Q3 2019 | Q3 2018 | Q3 2019 | Growth | ||||||||
$ | 2,355.6 | $ | 2,508.8 | 6.5% | $ | 2,355.6 | $ | 2,508.8 | 6.5% | |||||||
Operating Income | $ | 123.3 | $ | 187.2 | 51.9% | $ | 47.0 | $ | (0.8) | $ | 170.3 | $ | 186.4 | 9.4% | ||
Operating Margin (1) | 5.23% | 7.46% | 223 | bp | 7.23% | 7.43% | 20 bp | |||||||||
Net Income | $ | 90.8 | $ | 134.9 | 48.6% | $ | 29.2 | $ | (0.6) | $ | 120.0 | $ | 134.3 | 12.0% | ||
Diluted EPS | $ | 0.59 | $ | 0.91 | 54.2% | $ | 0.19 | $ | (0.01) | $ | 0.78 | $ | 0.90 | 15.4% |
- A The impact from acquisitions and acquisition related expenses this quarter on non-GAAP operating margin was a gain of 12 basis points. Excluding this impact, our Q3 2019 non-GAAP operating margin would have increased by 8 basis points.
Henry Schein, Inc.
Third Quarter 2019 Analyst Presentation Q3 2019 - Financial Highlights
From Continuing Operations
(in millions, except per share data)
Reconciling Items | ||||||||||||||||
2019-Restructuring, and Tax Credit related to | ||||||||||||||||
the Animal Health Spin-Off | ||||||||||||||||
2018-Restructuring, Litigation Settlements, | ||||||||||||||||
One Time Tax on Reorganization Related to | ||||||||||||||||
HS One, and Transitional Tax on Repatriated | ||||||||||||||||
GAAP Basis | Foreign Earnings | Non-GAAP | ||||||||||||||
Net Sales | Q3 2018 | Q3 2019 | Growth | Q3 2018 | Q3 2019 | Q3 2018 | Q3 2019 | Growth | ||||||||
$ | 2,355.6 | $ | 2,508.8 | 6.5% | $ | - | $ | - | $ | 2,355.6 | $ | 2,508.8 | 6.5% | |||
Operating Income | $ | 123.3 | $ | 187.2 | 51.9% | $ | 47.0 | $ | (0.8) | $ | 170.3 | $ | 186.4 | 9.4% | ||
Operating Margin | 5.23% | 7.46% | 223 | bp | 7.23% | 7.43% | 20 bp |
Henry Schein, Inc. | ||||||||||||||||||||||||||
Third Quarter 2019 Analyst Presentation | ||||||||||||||||||||||||||
Operating Income and Margin Highlights | ||||||||||||||||||||||||||
From Continuing Operations | ||||||||||||||||||||||||||
(in millions, except per share data) | GAAP | Reconciling Items | Non-GAAP | |||||||||||||||||||||||
Net Sales | 2016 | 2017 | 2018 | Q3 2019 | 2016 | 2017 | 2018 | Q3 2019 | Net Sales | 2016 | 2017 | 2018 | Q3 2019 | |||||||||||||
$ | 8,218.9 | $ | 8,883.4 | $ | 9,417.6 | $ | 2,508.8 | $ | 8,218.9 | $ | 8,883.4 | $ | 9,417.6 | $ | 2,508.8 | |||||||||||
Operating Income | $ | 591.8 | $ | 669.8 | $ | 600.6 | $ | 187.2 | $ | 38.6 | $ | 5.3 | $ | 92.9 | $ | (0.8) | Operating Income | $ | 630.5 | $ | 675.1 | $ | 693.5 | $ | 186.4 | |
Operating Margin | 7.20% | 7.54% | 6.38% | 7.46% | Operating Margin | 7.67% | 7.60% | 7.36% | 7.43% | |||||||||||||||||
Operating Income Growth % | 13% | -10% | Operating Income Growth % | 7% | 3% | |||||||||||||||||||||
Operating Margin % | 7.54% | 6.38% | Operating Margin % | 7.60% | 7.36% | |||||||||||||||||||||
CAGR | 1% | CAGR | 5% |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Henry Schein Inc. published this content on 05 November 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 November 2019 13:49:05 UTC